COVID Will Transform Cancer Care for Patients and Providers
June
1
With the novel coronavirus putting immunocompromised people in particular at risk and hospitals focusing on treating people with COVID-19, many people with cancer are experiencing disruptions in their treatment. And as studies show people forgoing diagnostic tests such as mammograms and colonoscopies, industry experts worry that as we emerge on the other side of the pandemic, there will be an uptick in these procedures — as well as an increase in people receiving a cancer diagnosis that’s at an advanced stage.
“COVID-19 has had a major impact upon all aspects of the health care industry,” says Winston Wong, Pharm.D., president of W-Squared Group. “Cancer care is no exception.”
© 2024 MMIT
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile